Form D · Biotechnology
Avra Medicines, Inc.
Lexington, MA · CIK 0001600380
Offering snapshot reported Mar 26, 2014 · SEC filing
- Reported sold
- $750 Offering amount: $750
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2014 | Initial | $750 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-214274
Source: Form D, filed Mar 26, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Albert Hsia | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
405 Waltham Street
Lexington, MA, 02421
Lexington, MA, 02421